Streetbeat News

Price Targets

BMY

Unusual options activity has been observed in Bristol-Myers Squibb (NYSE:BMY), with 10 strange trades detected. Whales have been targeting a price range of $40 to $75 for the company over the last 3 months. Barclays maintains an Equal-Weight rating with a price target of $65, while Credit Suisse maintains a Neutral rating with a price target of $72.

Portfolio Pulse from Benzinga Insights

May 25, 2023 | 8:03 pm

OCEA

Ocean Biomedical (NASDAQ:OCEA) shares are trading higher after the company announced its expected addition to the Russell 2000 Index on June 26, 2023. EF Hutton analyst Tony Butler initiated coverage on OCEA with a Buy rating and a price target of $17.

Portfolio Pulse from Ryan Gustafson

May 25, 2023 | 7:58 pm

NKE

A whale investor has taken a bearish stance on Nike (NYSE:NKE), with 80% of detected trades having bearish expectations. Whales have been targeting a price range of $95 to $140 for Nike over the last 3 months. Williams Trading downgraded Nike to Sell with a price target of $95.

Portfolio Pulse from Benzinga Insights

May 25, 2023 | 7:33 pm

TXN

Unusual options activity has been observed in Texas Instruments (NASDAQ:TXN), with 70% of investors taking a bearish stance. Whales have been targeting a price range of $165 to $200 for the company over the last 3 months. Analysts have maintained various ratings on the stock, with price targets ranging from $159 to $230.

Portfolio Pulse from Benzinga Insights

May 25, 2023 | 7:33 pm

EXC

In the last 3 months, 5 analysts have offered 12-month price targets for Exelon (NASDAQ:EXC), with an average price target of $46.4, a decrease of 1.69% from the previous average of $47.20.

Portfolio Pulse from Benzinga Insights

May 25, 2023 | 7:05 pm

TOL

Over the past 3 months, 5 analysts have published their opinion on Toll Brothers (NYSE:TOL) stock, with 1 bullish and 4 somewhat bullish ratings. The average 12-month price target for TOL is $76.6, which has increased by 16.77% over the past month.

Portfolio Pulse from Benzinga Insights

May 25, 2023 | 7:03 pm

SPLK

Needham analyst Mike Cikos reiterated a Buy rating on Splunk Inc. (NASDAQ:SPLK) and raised the price target to $125 from $120. Cikos praised Splunk's Q1 FY24 results, highlighting improving operating margins and free cash flows. He sees the company as an industry leader with solid products and a huge market opportunity.

Portfolio Pulse from Nabaparna Bhattacharya

May 25, 2023 | 6:52 pm

SNOW

Snowflake Inc. (NYSE:SNOW) shares are trading down after the company posted Q1 financial results and lowered product revenue guidance for fiscal year 2024. Q1 revenue was $623.6 million, beating estimates, but full-year product revenue is now expected to be $2.6 billion. Altimeter Capital's Brad Gerstner remains positive on Snowflake, highlighting recent AI-focused acquisitions.

Portfolio Pulse from Ryan Gustafson

May 25, 2023 | 6:49 pm

BNGO

EF Hutton has initiated coverage of Bionano Genomics (NASDAQ:BNGO) with a Buy rating and a price target of $1.75. BNGO's optical genome mapping (OGM) platform is set to disrupt cytogenetic analysis, targeting a global market of 10,000 labs. The company is releasing a next-generation, high-throughput OGM platform, expected to increase throughput by 13x.

Portfolio Pulse from Vandana Singh

May 25, 2023 | 6:47 pm

AEO

American Eagle Outfitters reported Q1 revenues of $1.08 billion, beating estimates, but higher markdowns and increased rent expenses weighed on the results. Telsey Advisory Group analyst Dana Telsey reiterated a Market Perform rating and lowered the price target to $12 from $17. The company now anticipates full-year sales to be flat to down low single digits Y/Y.

Portfolio Pulse from Nabaparna Bhattacharya

May 25, 2023 | 6:06 pm